Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MTOR | P42345 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | HBB | P68871 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL6465085 | 0.95 | LMNA (0.42) | LMNAALDH1A1MTORTP53GMNN | |
| Phosphoric Acid SCHEMBL20305093 | 0.95 | LMNA (0.42) | LMNAALDH1A1MTORTP53GMNN | |
| SCHEMBL30612476 | 0.89 | EGFR (0.39) | LMNAALDH1A1MTORTP53GMNN | |
| SCHEMBL9147640 | 0.89 | LMNA (0.44) | LMNAALDH1A1MTORTP53GMNN | |
| SCHEMBL9343755 | 0.88 | LMNA (0.44) | LMNAALDH1A1MTORTP53GMNN | |
| SCHEMBL31685308 | 0.86 | LMNA (0.36) | LMNAALDH1A1MTORTP53GMNN | |
| SCHEMBL31685168 | 0.84 | ADORA1 (0.42) | — | |
| SCHEMBL20305094 | 0.83 | UMPS (0.51) | SMN1; SMN2 | |
| SCHEMBL31685392 | 0.82 | LMNA (0.43) | LMNAALDH1A1MTORTP53GMNN | |
| SCHEMBL21113564 | 0.80 | MEN1 (0.54) | LMNAALDH1A1MTORTP53GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11038 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070938-A | Method for improving anti-tumor response by enhancing cellular immune response | 四川大学 | 2026-05-22 | — | — | CN | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| CN-122055140-A | Pharmaceutical composition containing nucleic acid construct and medical application thereof | 上海瑞宏迪医药有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4740010-A1 | NEGATIVE TUNE STANDARD FOR MASS SPECTROMETRY | Agilent Technologies, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| US-12577554-B2 | Methods for purification of messenger RNA | TRANSLATE BIO, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-20260069717-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNATX INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569572-B2 | Messenger RNA therapy for the treatment of Friedreich's ataxia | TRANSLATE BIO, INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| WO-2001030989-A2 | METHOD FOR CREATING DIVERGENT POPULATIONS OF NUCLEIC ACID MOLECULES AND PROTEINS | CYTOS BIOTECHNOLOGY AG (US) | 2001-05-03 | — | — | WO | claimed |
| WO-2000078941-A2 | METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2000-12-28 | — | — | WO | claimed |
| US-6063628-A | Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA | UNIVERSITY OF WASHINGTON (US) | 2000-05-16 | — | — | US | claimed |
| EP-0948256-A1 | INDUCTION OF VIRAL MUTATION BY INCORPORATION OF MISCODING RIBONUCLEOSIDE ANALOGS INTO VIRAL RNA | THE UNIVERSITY OF WASHINGTON (US) | 1999-10-13 | — | — | EP | claimed |
| WO-1998018324-A1 | INDUCTION OF VIRAL MUTATION BY INCORPORATION OF MISCODING RIBONUCLEOSIDE ANALOGS INTO VIRAL RNA | THE UNIVERSITY OF WASHINGTON (US) | 1998-05-07 | — | — | WO | claimed |
| US-5317013-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1994-05-31 | — | — | US | claimed |
| US-4948730-A | INDUCING INTERFERON PRODUCTION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-08-14 | — | — | US | claimed |
| US-4643992-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1987-02-17 | — | — | US | claimed |
| EP-0112632-A2 | Use of 8-substituted guanine derivatives in the manufacture of a medicament. | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1984-07-04 | — | — | EP | claimed |
| WO-1984001898-A1 | MODULATION OF ANIMAL CELLULAR RESPONSES WITH COMPOSITIONS CONTAINNG 8-SUBSTITUTED GUANINE DERIVATIVES | SCRIPPS CLINIC RES (US) | 1984-05-24 | — | — | WO | claimed |